4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-22-010396
President and CEO acquired 44,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stergiou Angelos M. President and CEO | 2022-01-31 | Grant or award | +44,000 | 165,167 | D | ||
| Derivatives | |||||||
| Stergiou Angelos M. President and CEO | 2022-01-31 | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | D | ||
Loading xslF345X03/tm225088-3_4seq1.xml…